Purchase Order 12405B21P0103

The Food and Drug Administration awarded a purchase order to Seqmatic, LLC for next-generation sequencing RNA reagents and testing services, valued at $99,900.00, on September 4, 2025. Seqmatic is a minority-owned, Asian-Pacific American-owned small business. Work will be performed in Silver Spring, Maryland, and completion is due March 6, 2027. The order calls for bulk RNA transcriptomics analysis on primary human hepatocytes to assess drug-associated adverse liver events, including 800 RNA...

The U.S. government awarded a $3,500 firm fixed-price purchase order to Seqll LLC for RNA sequencing services under Reference Quotation #170227L and Invoice #2155. The contract was awarded on May 18, 2017, with an ultimate completion date of the same day, indicating a short-duration engagement. The work was performed at Seqll's facility in Woburn, Massachusetts, with no small business set-aside designation applied. The funding originated from a civilian federal agency identified as the Northeast...

The U.S. government awarded a $38,250 firm fixed-price purchase order to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, for genome sequencing services utilizing RNA sequencing (RNAseq) technology. The contract was awarded on April 28, 2023, following a competitive solicitation posted on April 19, 2023, with a five-day turnaround to submission. Work will be performed in Auburn, Alabama, with a completion date extended to December 31, 2023, via modification P00001....

This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...

The Sequencing Center Inc. (UEI: U86HQDXFVDC8) was awarded a Total Small Business set-aside purchase order on September 7, 2017, for genome sequencing services. The contract has a ceiling value of $3,552.00 and operates under firm fixed-price terms. Performance is scheduled to be completed by October 31, 2017, with work to be performed in Fort Collins, Colorado. The contract was funded by a civilian agency within the Northeast Area. As a small business set-aside purchase order, this award...

This is a firm fixed-price delivery order awarded by a civilian federal agency to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The award is for the purchase of an ILLUMINA NEXTSEQ 2000 SEQUENCER ($234,500.00), a NEXTSEQ 2000 SILVER SUPPORT PLAN ($40,719.25), and shipping ($2,345.00), with a trade-in discount of 30% ($100,500.00) off the list price of $335,000.00 for a NextSeq 500 Sequencer. The total ceiling value of the award is...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a NEXTSEQ 500 HIGH OUTPUT KIT (300 CYCLES) with a ceiling value of $77,520.00. The award was made on August 14, 2014 with a period of performance ending September 30, 2017. This award does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of...

This is a $32,190 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The contract is for testing and sequencing services, including RNA sequencing (bulk and single-cell), DNA sequencing, whole genome/exome sequencing, and metagenomics sequencing, as well as associated...

This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...

The USDA APHIS has awarded a $24,271.68 firm fixed price delivery order against an existing contract vehicle to Illumina, Inc. to provide preventative maintenance for a NextSeq 2000 sequencer. The sequencer will be used by APHIS' Plant Protection and Quarantine program to detect pathogens in imported plants through high-throughput DNA sequencing. The one-year order, with performance in Calverton, Maryland, will ensure the sequencer functions properly to support APHIS' agricultural safeguarding...